ArticleTurk gogus kalp damar cerrahisi dergisi2025
Risk factors of hemoptysis recurrence after bronchial artery embolization and patient feedbacks.
Article in Turk gogus kalp damar cerrahisi dergisi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predictors of Recurrence Following Bronchial Artery Embolisation (BAE) for Haemoptysis: A Systematic Review and Evidence Synthesis Analyses Using SWiM Guidelines.Cardiovascular and interventional radiology · 2026Pooled it
- Comment on: Risk factors of hemoptysis recurrence after BAE.Turk gogus kalp damar cerrahisi dergisi · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim of this study is to identify risk factors for recurrence of hemoptysis after bronchial artery embolization and to evaluate patient feedbacks on this intervention. Methods: Between August 2013 and October 2022, a total of 122 patients (83 males, 39 females; mean age: 59.7±17.3 years; range, 13 to 91 years) who underwent bronchial artery embolization were retrospectively analyzed. The endpoint event was hemoptysis recurrence or death. Baseline data of the patients, technical and clinical success rates, complications, postoperative recovery time in hospital and patient satisfaction and re-acceptance rates were evaluated via a questionnaire. Results: During follow-up, 24 patients died. A total of 50 patients experienced recurrence, and the overall recurrence rate was 40.98%. Patients with embolization of single culprit artery had a higher recurrence-free survival rate (p=0.049). Of 97 respondents, 81 were satisfied with the result of the procedure and 84 gave consent for re-intervention, if necessary. Conclusion: Bronchial artery embolization is a safe and effective method of hemoptysis suppression, particularly for those with embolization of single culprit artery. Better suppression of hemoptysis and strengthening communication with patients in the perioperative period can improve the patient satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.